uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that two abstracts have been accepted for presentation at the International Society on Thrombosis and Hemostasis (ISTH) Congress held in Berlin, Germany, July 8 – 13, 2017.


Share this story, choose your platform!